1.25 semaglutide The FDA approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 and reduced Wegovy Pill | UK's First

Essentially, PRP helps extend the hairs active growth phase, giving your hair a better chance to grow longer and stronger before shedding

Targeting PI3K/mTOR pathways has shown promise in preclinical trials, with omipalisib being well-tolerated in IPF subjects [148, 149]

What are the NHS-approved alternatives to retatrutide for weight management

Pathogen-induced changes in the antioxidant status of the apoplast in barley leaves

doi: 10.3389/fnut.2026.1804917 Received 05 February 2026 Revised 04 March 2026 Accepted 16 March 2026 Published 31 March 2026 Volume 13 - 2026 Edited by Berenice M Romn Calleja, National Institute of Medical Sciences and Nutrition Salvador Zubirn, Mexico Reviewed by Anindita Banerjee, Indian Council of Medical Research (ICMR), India Venkateswararao Eeda, University of Oklahoma Health Sciences Center, United States Updates Copyright 2026 Chen, Zou, Li, Liu, Liu, Yao, Peng, Liang, Chen, Huang and Huang